Company Overview and News
April 19 (Reuters) - Canada’s main stock index was slightly lower on Thursday, as declines in financials and consumer cyclical companies weighed, but strong gains in energy shares that benefited from a rally in oil prices kept further losses in check.
TORONTO, April 18 (Reuters) - Canada’s main stock index rose for the fifth straight day on Wednesday to reach a four-week high, as energy and metal mining companies led broad-based gains, boosted by higher commodity prices.
April 18 (Reuters) - Canada’s main stock index rose for the fifth day in a row on Wednesday, to hit a near-one month high, as energy stocks gained with oil prices and banks moved higher after the Bank of Canada struck a more hawkish tone on the future of interest rates.
April 18 (Reuters) - Canada’s main stock index rose sharply after opening at a near one-month high on Wednesday, helped by gains in energy and material companies, and after the Bank of Canada issued an optimistic economic growth outlook.
April 16 (Reuters) - Canada’s benchmark index was slightly higher on Monday, helped by industrial shares and waning fears of an escalating conflict in Syria following the weekend’s U.S.-led air strikes.
April 11 (Reuters) - Canada’s main stock index reversed course to trade higher on Wednesday morning as escalating tensions between the United States and Russia over Syria pushed up gold and crude oil prices.
April 10 (Reuters) - Canada’s main stock index rose on Tuesday as higher oil prices lifted energy shares and trade war worries receded after Chinese President Xi Jinping promised to cut import tariffs.
Natural Gas Liquids (NGLs) Industry report offers a comprehensive insight into the development policies and plans in addition to manufacturing processes and cost structures. On the basis of product, this report displays the Cost Structure, Sales Revenue, Sales Volume, Gross Margin, market share and growth rate.
TORONTO (Bloomberg) -- Investors have bailed on the Canadian energy sector, although mergers & acquisitions (M&A) north of the border could provide a much needed catalyst, barring pipeline and political developments. Raymond James recently called upon John Connor to help save the space, and BMO Capital Markets is now calling for consolidation.
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
April 5 (Reuters) - Canada’s main stock index rose more than 1 percent on Thursday, led by a surge in energy stocks and rising confidence that NAFTA talks will result in a positive outcome.
April 4 (Reuters) - Canada’s main stock index fell to its lowest level in nearly two months on Wednesday, dragged by financial and energy stocks, as China’s retaliatory tariffs against the United States intensified fears of a trade war.
LONDON -- Glencore PLC added to its growing portfolio of coal assets with a $1.7 billion investment in a pair of Australian producers -- part of a bet by the mining giant that demand for coal in Southeast Asia will remain strong, even as competitors shy away from the stuff.
CALGARY, Alberta, April 03, 2018 (GLOBE NEWSWIRE) -- Titanium Corporation Inc. ("Titanium" or the "Company") (TSX-V:TIC) is pleased to announce the award of engineering contracts for the front end engineering design (the "FEED") related to implementation of the Company's CVW™ technology at Canadian Natural Resources Limited's Horizon oil sands site. Stantec Inc. has been awarded the engineering contract for the FEED of the onsite concentrator and minerals separation facilities including site integration and services.
2018-04-18 - Asif
History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...
2018-04-16 - Asif
Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...
2018-04-16 - Asif
Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...
2018-04-15 - Asif
Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...
2018-04-12 - Asif
Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...
as of ET